IDiyas

For the Inventor, By the Inventor

Middletown, CT, United States of America

John E Starrett, Jr

USPTO Granted Patents = 34 


Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 612(Granted Patents)


Location History:

  • Middletown, CT (US) (1990 - 2013)
  • Waterford, CT (US) (2017 - 2019)

Company Filing History:

goldMedal29 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal2 out of 22 
 
Institute of Organic Chemistry and Biochemistry of the Academy of
 patents
bronzeMedal2 out of 21 
 
Rega Stichting, V.z.w.
 patents
4. 2 out of 637 
 
Bristol-myers Company
 patents
5. 1 out of 36 
 
Bristol-myers Squibb
 patents
where one patent can have more than one assignee

Years Active: 1990-2019

Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents
1. 10174024 - 5H-pyrido[3,2-B]indole compounds as anticancer agents (2019-01-08),
2. 9751879 - Tricyclic compounds as anticancer agents (2017-09-05),
3. 9725449 - Tricyclic compounds as anticancer agents (2017-08-08),
4. 8350084 - Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production (2013-01-08),
5. 8093276 - Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production (2012-01-10),
6. 8084477 - Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production (2011-12-27),
7. 8044077 - Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production (2011-10-25),
8. 7169803 - N-substituted prodrugs of fluorooxindoles (2007-01-30),
9. 7151180 - Potassium channel modulators (2006-12-19),
10. 7091202 - 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators (2006-08-15),
11. 6930100 - Phosphate prodrugs of fluoroxindoles (2005-08-16),
12. 6613786 - Thiophenyl triazol-3-one derivatives as smooth muscle relaxants (2003-09-02),
13. 6297241 - Carbamate derivatives of diaryl 1,3,4-oxadiazolone (2001-10-02),
14. 6271249 - Diphenyl imidazoles as potassium channel modulators (2001-08-07),
15. 6184231 - 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators (2001-02-06),

Title: John E Starrett, Jr: Innovator in Anticancer Compounds

Introduction: John E Starrett, Jr., based in Middletown, Connecticut, is a prolific inventor with an impressive portfolio of 34 patents. His work primarily focuses on the development of novel compounds for therapeutic applications, particularly in the field of oncology.

Latest Patents: Among his latest innovations are two significant patents concerning 5H-pyrido[3,2-B]indole compounds as anticancer agents. This invention relates to tricyclic compounds that exhibit promising potential in treating various disorders, notably cancer. The patented formulas include pharmaceutically acceptable compositions that offer methods for effectively utilizing these compounds in therapeutic applications.

Career Highlights: John’s professional journey has seen him contribute to well-regarded organizations like Bristol-Myers Squibb Company and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. His expertise in the field of organic chemistry has made a considerable impact on drug development processes aimed at combatting cancer.

Collaborations: Throughout his career, John E Starrett, Jr. has collaborated with notable professionals, including Piyasena Hewawasam and Muzammil M Mansuri. These partnerships have enhanced the innovation pipeline and allowed for the exchange of valuable ideas and research to create effective anticancer agents.

Conclusion: John E Starrett, Jr. exemplifies the spirit of innovation in the field of pharmacology, particularly with his advancements in anticancer compounds. His extensive patent portfolio and professional collaborations continue to contribute significantly to cancer research and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…